Anglo-Swedish drug maker AstraZeneca will pay up to $1.15 billion for a U.S. developer of drugs for respiratory diseases, AstraZeneca said Monday.
Medical device maker PMD Healthcare has launched what it calls the first personal spirometer to monitor lung function, the company said.